Business Description
Transcenta Holding Ltd
ISIN : KYG9005B1041
Compare
Compare
Traded in other countries / regions
06628.Hong Kong IPO Date
2021-09-29Description
Transcenta Holding Ltd is a clinical-stage biopharmaceutical company with fully integrated capacities in discovery, research, development, and manufacturing. It is developing nine therapeutic antibody molecules for oncology and selected non-oncology indications including bone and kidney disorders. Geographically the company operates in China (the PRC) and the USA.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.03 | |||||
| Equity-to-Asset | 0.61 | |||||
| Debt-to-Equity | 0.39 | |||||
| Debt-to-EBITDA | -1.04 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -3.43 | |||||
| Beneish M-Score | -2.47 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -12.4 | |||||
| 3-Year EBITDA Growth Rate | -14.4 | |||||
| 3-Year EPS without NRI Growth Rate | -13.8 | |||||
| 3-Year FCF Growth Rate | -16.6 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 25.51 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 75.2 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 55.14 | |||||
| 9-Day RSI | 48.34 | |||||
| 14-Day RSI | 43.44 | |||||
| 6-1 Month Momentum % | -56.55 | |||||
| 12-1 Month Momentum % | -83.02 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.08 | |||||
| Quick Ratio | 1.04 | |||||
| Cash Ratio | 0.81 | |||||
| Days Inventory | 431.36 | |||||
| Days Sales Outstanding | 767.15 | |||||
| Days Payable | 1652.08 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 0.8 | |||||
| Shareholder Yield % | 23.96 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 26 | |||||
| Operating Margin % | -1530.6 | |||||
| Net Margin % | -1601.93 | |||||
| FCF Margin % | -1257.5 | |||||
| ROE % | -33.92 | |||||
| ROA % | -21.08 | |||||
| ROIC % | -23.69 | |||||
| 3-Year ROIIC % | -497.21 | |||||
| ROC (Joel Greenblatt) % | -79.82 | |||||
| ROCE % | -29.07 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 10.17 | |||||
| PB Ratio | 0.27 | |||||
| Price-to-Tangible-Book | 0.73 | |||||
| EV-to-EBIT | -0.68 | |||||
| EV-to-EBITDA | -0.69 | |||||
| EV-to-Revenue | 10.45 | |||||
| EV-to-FCF | -0.83 | |||||
| Earnings Yield (Greenblatt) % | -147.06 | |||||
| FCF Yield % | -115.61 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Transcenta Holding Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 24.344 | ||
| EPS (TTM) (HK$) | -0.968 | ||
| Beta | -0.52 | ||
| Volatility % | 39.03 | ||
| 14-Day RSI | 43.44 | ||
| 14-Day ATR (HK$) | 0.052793 | ||
| 20-Day SMA (HK$) | 0.603 | ||
| 12-1 Month Momentum % | -83.02 | ||
| 52-Week Range (HK$) | 0.5 - 4 | ||
| Shares Outstanding (Mil) | 434.07 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Transcenta Holding Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Transcenta Holding Ltd Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Transcenta Holding Ltd Frequently Asked Questions
What is Transcenta Holding Ltd(HKSE:06628)'s stock price today?
The current price of HKSE:06628 is HK$0.61. The 52 week high of HKSE:06628 is HK$4.00 and 52 week low is HK$0.50.
When is next earnings date of Transcenta Holding Ltd(HKSE:06628)?
The next earnings date of Transcenta Holding Ltd(HKSE:06628) is 2025-03-27 Est..
Does Transcenta Holding Ltd(HKSE:06628) pay dividends? If so, how much?
Transcenta Holding Ltd(HKSE:06628) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers